Michaela Jackson

472 total citations
8 papers, 243 citations indexed

About

Michaela Jackson is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michaela Jackson has authored 8 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michaela Jackson's work include Neurogenetic and Muscular Disorders Research (3 papers), RNA Interference and Gene Delivery (2 papers) and RNA Research and Splicing (2 papers). Michaela Jackson is often cited by papers focused on Neurogenetic and Muscular Disorders Research (3 papers), RNA Interference and Gene Delivery (2 papers) and RNA Research and Splicing (2 papers). Michaela Jackson collaborates with scholars based in United States, Netherlands and Russia. Michaela Jackson's co-authors include Frank Rigo, C. Frank Bennett, Hyun Yong Jeon, Adrian R. Krainer, Juergen Scharner, John E. Wilkinson, Wai Kit, Ana S.H. Costa, Kuan‐Ting Lin and Leslie B. Gordon and has published in prestigious journals such as Nature Medicine, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Michaela Jackson

8 papers receiving 239 citations

Peers

Michaela Jackson

MB

CR

GENET

PHYSI

ONCOL

Mariaelena Pistoni Italy

Violeta Rayon-Estrada United States

Italia Aiello Italy

Yu Shen China

Krystine Garcia‐Mansfield United States

Rubén Fernández Spain

Marit B. de Wissel Netherlands

Sylvain Hansen Belgium

Lea Kiefer United States

Eva Kling Germany

Mariaelena Pistoni Italy

Michaela Jackson

240 ×1.2

MB

62 ×1.5

CR

30 ×1.4

GENET

19 ×1.0

PHYSI

29 ×1.8

ONCOL

Citations per year, relative to Michaela Jackson Michaela Jackson (= 1×) peers Mariaelena Pistoni

Countries citing papers authored by Michaela Jackson

Since Specialization

Citations

This map shows the geographic impact of Michaela Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Jackson more than expected).

Fields of papers citing papers by Michaela Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Jackson. The network helps show where Michaela Jackson may publish in the future.

Co-authorship network of co-authors of Michaela Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela Jackson. A scholar is included among the top collaborators of Michaela Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela Jackson. Michaela Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kit, Wai, Juergen Scharner, Ana S.H. Costa, et al.. (2021). ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth. Cancer Research. 82(5). 900–915. 79 indexed citations

2.

Hamer, Bianca den, Anita van den Heuvel, Marnix Franken, et al.. (2021). Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy. Molecular Therapy — Nucleic Acids. 26. 813–827. 19 indexed citations

3.

Puttaraju, M., Michaela Jackson, Stéphanie Klein, et al.. (2021). Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome. Nature Medicine. 27(3). 526–535. 45 indexed citations

4.

Jodelka, Francine M., Anthony J. Hinrich, Tyler B. Johnson, et al.. (2020). Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature Medicine. 26(9). 1444–1451. 34 indexed citations

5.

Nikan, Mehran, Michael Tanowitz, Chrissa A. Dwyer, et al.. (2020). Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides. Journal of Medicinal Chemistry. 63(15). 8471–8484. 28 indexed citations

6.

Ling, Karen, Michaela Jackson, Duah Alkam, et al.. (2018). Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis. Neurobiology of Disease. 114. 174–183. 18 indexed citations

7.

Prakash, Thazha P., Jinghua Yu, Garth A. Kinberger, et al.. (2018). Evaluation of the effect of 2′-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3774–3779. 14 indexed citations

8.

Sidwell, Robert W., Min‐Hui Wong, Kevin W. Bailey, et al.. (2001). Utilization of Alpha-1-Acid Glycoprotein Levels in the Serum as a Parameter for in Vivo Assay of Influenza Virus Inhibitors. Antiviral chemistry & chemotherapy. 12(6). 359–365. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact